Litcius/Paper detail

Association of Phosphodiesterase-5 Inhibitor Treatment With Improved Survival in Pulmonary Hypertension Associated With COPD in the Pulmonary Vascular Research Institute GoDeep Meta-Registry

Khodr Tello, Athiththan Yogeswaran, Raphael W. Majeed, David G. Kiely, Allan Lawrie, Evan L. Brittain, Jeffrey Annis, Horst Olschewski, Gábor Kovács, Paul M. Hassoun, Aparna Balasubramanian, Ziad Konswa, Andrew J. Sweatt, Roham T. Zamanian, Martin R. Wilkins, Luke Howard, Alexandra Arvanitaki, George Giannakoulas, Héctor Cajigas, Robert P. Frantz, Paul Williams, Marlize Frauendorf, Kurt Marquardt, Tobiah Antoine, Meike Fuenderich, Manuel J. Richter, Friedrich Grimminger, Hossein Ardeschir Ghofrani, Jochen Wilhelm, Werner Seeger

2024CHEST Journal21 citationsDOIOpen Access PDF

Topics & Concepts

COPDMedicinePulmonary hypertensionContext (archaeology)PharmacotherapyInternal medicineCardiologyIntensive care medicineBiologyPaleontologyPulmonary Hypertension Research and TreatmentsPhosphodiesterase function and regulationTransplantation: Methods and Outcomes
Association of Phosphodiesterase-5 Inhibitor Treatment With Improved Survival in Pulmonary Hypertension Associated With COPD in the Pulmonary Vascular Research Institute GoDeep Meta-Registry | Litcius